162 related articles for article (PubMed ID: 21641061)
1. Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice.
Tziakas D; Chalikias G; Stakos D; Apostolakis S; Adina T; Kikas P; Alexoudis A; Passadakis P; Thodis E; Vargemezis V; Konstantinides S
Int J Cardiol; 2013 Feb; 163(1):46-55. PubMed ID: 21641061
[TBL] [Abstract][Full Text] [Related]
2. Validation of a new risk score to predict contrast-induced nephropathy after percutaneous coronary intervention.
Tziakas D; Chalikias G; Stakos D; Altun A; Sivri N; Yetkin E; Gur M; Stankovic G; Mehmedbegovic Z; Voudris V; Chatzikyriakou S; Garcia-Moll X; Serra A; Passadakis P; Thodis E; Vargemezis V; Kaski JC; Konstantinides S
Am J Cardiol; 2014 May; 113(9):1487-93. PubMed ID: 24630389
[TBL] [Abstract][Full Text] [Related]
3. A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes.
Zeng JF; Chen SQ; Ye JF; Chen Y; Lei L; Liu XQ; Liu Y; Wang Y; Lin JJ; Chen JY
Clin Exp Nephrol; 2019 Jul; 23(7):969-981. PubMed ID: 31049747
[TBL] [Abstract][Full Text] [Related]
4. A novel risk assessment model of contrast-induced nephropathy after percutaneous coronary intervention in patients with diabetes.
Yao ZF; Shen H; Tang MN; Yan Y; Ge JB
Basic Clin Pharmacol Toxicol; 2021 Feb; 128(2):305-314. PubMed ID: 32991776
[TBL] [Abstract][Full Text] [Related]
5. A novel risk score model for prediction of contrast-induced nephropathy after emergent percutaneous coronary intervention.
Lin KY; Zheng WP; Bei WJ; Chen SQ; Islam SM; Liu Y; Xue L; Tan N; Chen JY
Int J Cardiol; 2017 Mar; 230():402-412. PubMed ID: 28043662
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Two Risk Models in Predicting the Incidence of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention.
Araujo GN; Wainstein MV; McCabe JM; Huang PH; Govindarajulu US; Resnic FS
J Interv Cardiol; 2016 Oct; 29(5):447-453. PubMed ID: 27377243
[TBL] [Abstract][Full Text] [Related]
7. Novel risk score of contrast-induced nephropathy after percutaneous coronary intervention.
Ji L; Su X; Qin W; Mi X; Liu F; Tang X; Li Z; Yang L
Nephrology (Carlton); 2015 Aug; 20(8):544-51. PubMed ID: 25706048
[TBL] [Abstract][Full Text] [Related]
8. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
[TBL] [Abstract][Full Text] [Related]
9. CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.
Wang Y; Zhao HW; Zhang XJ; Chen BJ; Yu GN; Hou AJ; Luan B
BMC Cardiovasc Disord; 2019 Mar; 19(1):74. PubMed ID: 30922230
[TBL] [Abstract][Full Text] [Related]
10. Predictors of contrast-induced nephropathy in chronic total occlusion percutaneous coronary intervention.
Lin YS; Fang HY; Hussein H; Fang CY; Chen YL; Hsueh SK; Cheng CI; Yang CH; Chen CJ; Hang CL; Yip HK; Wu CJ
EuroIntervention; 2014 Feb; 9(10):1173-80. PubMed ID: 24561734
[TBL] [Abstract][Full Text] [Related]
11. The predictive value of the renal resistive index for contrast-induced nephropathy in patients with acute coronary syndrome.
Xu ZR; Chen J; Liu YH; Liu Y; Tan N
BMC Cardiovasc Disord; 2019 Feb; 19(1):36. PubMed ID: 30744553
[TBL] [Abstract][Full Text] [Related]
12. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
Worasuwannarak S; Pornratanarangsi S
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
[TBL] [Abstract][Full Text] [Related]
13. Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease.
Demir OM; Lombardo F; Poletti E; Laricchia A; Beneduce A; Maccagni D; Slavich M; Giannini F; Carlino M; Margonato A; Cappelletti A; Colombo A; Azzalini L
Am J Cardiol; 2018 Dec; 122(11):1837-1842. PubMed ID: 30292337
[TBL] [Abstract][Full Text] [Related]
14. Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention.
Zhang JY; Wang Q; Wang RT; Li F; Cheng HX; Lian K; Liu Y; Tao L
BMC Cardiovasc Disord; 2019 Jul; 19(1):160. PubMed ID: 31269899
[TBL] [Abstract][Full Text] [Related]
15. Risk scoring system to predict contrast induced nephropathy following percutaneous coronary intervention.
Victor SM; Gnanaraj A; S V; Deshmukh R; Kandasamy M; Janakiraman E; Pandurangi UM; Latchumanadhas K; Abraham G; Mullasari AS
Indian Heart J; 2014; 66(5):517-24. PubMed ID: 25443605
[TBL] [Abstract][Full Text] [Related]
16. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
Chong E; Shen L; Poh KK; Tan HC
Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
[TBL] [Abstract][Full Text] [Related]
17. Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
Kurtul A; Yarlioglues M; Murat SN; Demircelik MB; Acikgoz SK; Ergun G; Duran M; Cetin M; Ornek E
Angiology; 2015 May; 66(5):433-40. PubMed ID: 24834929
[TBL] [Abstract][Full Text] [Related]
18. Relation of uric acid and contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention in the ED.
Saritemur M; Turkeli M; Kalkan K; Tanboga İH; Aksakal E
Am J Emerg Med; 2014 Feb; 32(2):119-23. PubMed ID: 24238488
[TBL] [Abstract][Full Text] [Related]
19. Elevated high-sensitivity C-reactive protein combined with procalcitonin predicts high risk of contrast-induced nephropathy after percutaneous coronary intervention.
Gu G; Yuan X; Zhou Y; Liu D; Cui W
BMC Cardiovasc Disord; 2019 Jun; 19(1):152. PubMed ID: 31234798
[TBL] [Abstract][Full Text] [Related]
20. CHA2DS2-VASc score as a novel predictor for contrast-induced nephropathy after percutaneous coronary intervention in acute coronary syndrome.
Chaudhary AK; Pathak V; Kunal S; Shukla S; Pathak P
Indian Heart J; 2019; 71(4):303-308. PubMed ID: 31779857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]